Four Genes Identified that Influence Levels of ‘Bad’ Cholesterol; May Be New Targets for Treatments to Reduce Heart Disease Risk
SAN ANTONIO, May 15, 2013 - Scientists at the Texas Biomedical Research Institute have identified four ...
By Scott Bailey, San Antonio Business Journal The University of Texas Health Science Center at San Antonio ...
[Minneapolis, Minnesota] Advanced Circulatory Systems, Inc., makers of multiple medical devices providing perfusion therapy to the first responder and hospital marketplace, has named Philip W. Faris, CEO and Managing Partner of ProSavant International, Executive Advisor and Member at Large of the Board of Directors. In these roles, Faris will provide experienced leadership and guidance as the company secures investment to stage focused growth initiatives and move the company's products into standard practices of medicine.
Advanced Circulatory has developed a novel platform therapy called Perfusion on DemandTM- a therapy that has life-saving implications for multiple emergency medical conditions with a total estimated global market opportunity of $3.3 Billion. Perfusion on Demand is a non-invasive therapy that increases circulation, protecting the heart, brain and other vital organs when blood flow is compromised. This gives rescuers and caregivers the potential to return people to a full life after severe medical emergencies, including sudden cardiac arrest, hemorrhagic shock and traumatic brain injury. The company manufactures and markets the ResQPOD® (Perfusion on Demand) and the ResQGARDTM Impedance Threshold Devices.
"Phil's knowledge and experience will help us move Advanced Circulatory's products to the next level," commented President Mike Black. "We are thrilled to be working with him."
Faris has a distinguished track record of building market-leading companies in emerging medical markets and has successfully performed as CEO for over three decades in start-up, early stage, and high-growth organizations. He is currently CEO and managing partner at ProSavant International, a strategic consulting firm for the medical device and biotechnology space. He also serves as Executive Chairman of the Board at Innovative Trauma Care (an early-stage medical device company developing and marketing point of injury solutions), on the Executive Committee of BioMed SA (a non-profit organization promoting the bioscience industry in San Antonio, Texas), and as a Board Member and Senior Advisor for Vivo Biosciences (an Alabama-based biotechnology company). Through his career, Faris has acted as CEO and Director at Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation and many other medical device, biotechnology and health care companies.